Can patient self-evaluation of functional status be used for evaluation of impairment of motor function in Guillain-Barré syndrome? Mapping clinician- and patient-reported outcomes in a phase 3 study of eculizumab in Japan
Background and purposeGuillain-Barré syndrome (GBS) is an autoimmune neurological disorder characterized by muscle weakness. In clinical trials, treatment benefit and disease severity are typically measured using clinician-reported outcome measures like the Hughes Functional Grading Scale (HFGS). Ho...
Saved in:
| Main Authors: | Antoine Regnault, Angély Loubert, Stéphane Quéré, Qun Lin, Glen Frick, Hirokazu Ishida, Yuko Abeta, Helene Chevrou-Severac |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-02-01
|
| Series: | Frontiers in Neurology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2025.1463938/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Developing a set of patient‐centered outcomes for routine use in endometriosis: An international Delphi study
by: Alba Nicolas‐Boluda, et al.
Published: (2024-01-01) -
Achieving Optimal Treatment Targets and Minimal Disease Activity with Upadacitinib for Moderate-to-Severe Atopic Dermatitis: Integrated Analysis of Phase 3 Studies (Measure Up 1 and 2)
by: Jonathan I. Silverberg, et al.
Published: (2025-07-01) -
Systematic review of the tools and outcomes for the assessment of acute radiation dermatitis severity
by: Partha Patel, et al.
Published: (2025-07-01) -
Impact of Achieving Optimal Treatment Targets and Minimal Disease Activity on Health-Related Quality of Life and Satisfaction in Patients with Atopic Dermatitis
by: Jonathan I. Silverberg, et al.
Published: (2025-06-01) -
Global aHUS Registry Analysis of Patients Switching to Ravulizumab From Eculizumab
by: Franz Schaefer, et al.
Published: (2024-09-01)